ÌÚ²©»á¹ÙÍø


TEL:17312606166£¨É¡Ë¾Àí£©

VRͼ±ê°×É« VRͼ±êÐþÉ«
X

ÌÚ²©»á¹ÙÍøÁÙ´²Ç°´ó¶¯ÎïʵÑéÖÐÐÄ

ÓëÎÒÃÇÈ¡µÃÁªÏµ

    17312606166

°ßÂíÓãÊÔÑ飺±ÇÄÚ×¢ÈëSARS

ÄúµÄλÖãºÊ×Ò³ >> ÐÐÒµ¶¯Ì¬ >> ×ÊѶ

ÕªÒª£ºÐá¾õËðʧ£¨Ðá¾õËðʧ£©ÊÇ SARS-CoV-2 ѬȾµÄÆÕ±éÖ¢×´¡£ Ðá¾õËðʧ¿ÉÄÜÓÉ·ÇÉñ¾­ÔªÏ¸°ûѬȾºÍ±ÇÉÏƤËðÉËÇý¶¯µÄ¼¸ÖÖ»úÖÆÀ´Ú¹ÊÍ £¬¶ø²»ÊÇÐá¾õ¸ÐÊÜÉñ¾­Ôª (OSN) µÄÖ±½ÓѬȾ¡£ÎÒÃÇ·¢Ã÷²¡¶¾ÂÑ°××ãÒÔÒýÆðÓ²¹ÇÓãÐá¾õÆ÷¹Ù£¨OO£©µÄÉñ¾­ÃâÒß·´Ó¦¡£ÎÒÃǼÙÉèSARS-CoV-2´ÌÍ»ÂÑ°××ãÒÔÒýÆðÐá¾õËðÉ˺ÍÐá¾õ¹¦Ð§ÕÏ°­¡£³ÉÄê°ßÂíÓãÄ£×ÓÏÔʾ±ÇÄÚ×¢ÈëµÄ SARS-CoV-2 S RBD Ö÷ÒªÓëÐá¾õÆ÷¹ÙµÄ·Ç¸ÐÊÜÉÏƤϸ°ûÍŽá £¬²¢µ¼ÖÂÑÏÖصÄÐá¾õ×éÖ¯²¡Àíѧ £¬ÆäÌØÕ÷ÊÇÏËëËðʧ¡¢³öѪºÍË®Öס£È»¶ø £¬ÔÚ SARS-CoV-2 S RBD ×¢ÈëµÄÓãÖÐûÓз¢Ã÷¶ÔʳÎïµÄÐÐΪƫºÃËðʧ¡£³ÉÄê°ßÂíÓãÐá¾õÆ÷¹ÙµÄµ¥Ï¸°ûRNAÐòÁÐÅú×¢ £¬Ö§³Öϸ°û¡¢ÄÚƤϸ°ûºÍËèϵϸ°û´ØÖÐÐá¾õÊÜÌå±í´ïºÍÑ×Ö¢·´Ó¦ÆÕ±éȱʧ £¬Í¬Ê±TregÊýÄ¿ïÔÌ­¡£ÌÚ²©»á¹ÙÍøЧ¹ûÅú×¢ £¬±ÇÄÚSARS-CoV-2 S RBD×ãÒÔ¶Ô°ßÂíÓãÐá¾õϵͳÔì³É½á¹¹ºÍ¹¦Ð§ËðÉË¡£ÕâЩ·¢Ã÷¿ÉÄܶԱÇÄÚ½ÓÖÖSARS-CoV-2ÒßÃç¾ßÓÐÖ¸µ¼ÒâÒå¡£

Òªº¦´Ê£ºSARS-COV-2  ´ÌÍ»ÂÑ°×  °ßÂíÓã  ¶¯ÎïÄ£×Ó Ðá¾õËðÉË  EOG   Ðá¾õÊÜÌå±í´ï

¼ò½é£ºÆøÏ¢ÑÏÖØÓ°Ï춯ÎïµÄÐÐΪºÍÉúÑÄ¡£SARS-CoV-2 ѬȾµÄÒ»¸ö±ê¼ÇÊǼ±ÐÔÐá¾õËðʧ»òÐá¾õËðʧ¡£ËäÈ»´ó´ó¶¼±¨¸æÐá¾õËðʧµÄ COVID-19 »¼ÕßÔÚ·¢²¡ºó 2 ÖÜ×îÏÈÐá¾õ»Ö¸´ £¬µ«Ò»Ð¡²¿·Ö£¨~5%£©±¨¸æ³ÆÒ»¸öÔºóÒ»Á¬±£´æÐá¾õÕÏ°­¡£²¡¶¾ÒýÆðµÄÐá¾õËðʧ²¢·Ç SARS-CoV-2 ѬȾËù¶ÀÍ̵Ä£» ÆäËûºôÎüµÀ²¡¶¾ £¬Èç±Ç²¡¶¾¡¢Á÷¸Ð¡¢¸±Á÷¸ÐºÍ¼¾½ÚÐÔ¹Ú×´²¡¶¾ £¬»áµ¼ÖÂÈËÀàÐá¾õÕÏ°­¡£ËäÈ» COVID-19 »¼ÕßÐá¾õËðʧ¼òÖ±ÇлúÖÆÉв»ÇåÎú £¬µ«ÒѾ­Ìá³öÁËһϵÁÐDZÔڵĿÉÄÜÔµ¹ÊÔ­ÓÉ¡£ Ê×ÏÈ £¬²¡¶¾ÒýÆðµÄÐá¾õËðʧ¿ÉÄÜÊÇÓÉÓÚ±ÇÇ»µÄÑ×Ö¢ÐÔÛÕ±Õ £¬COVID-19 »¼ÕßµÄÐáÉÏƤ (OE) ÖеĴÙÑ×ϸ°ûÒò×ÓˮƽÉý¸ß¡£ÔÚСÊóOEÖÐ £¬IÐÍ×ÌÈÅËصÄÓÕµ¼µ¼ÖÂÐá¾õÊÜÌ壨OR£©±í´ïµÄÆÕ±éËðʧ £¬ÕâÅú×¢×ÝÈ»ÔÚûÓлîÔ¾²¡¶¾¸´ÖƵÄÇéÐÎÏ £¬Ñ×Ö¢Ò²¿ÉÄܵ¼ÖÂÐá¾õ¹¦Ð§ÕÏ°­¡£È»¶ø £¬´ó×Ú COVID-19 »¼Õß±¨¸æÐá¾õÕÏ°­Óë±ÇÇ»Ö×ÕÍÎÞ¹Ø £¬Òò´ËÐèÒª½øÒ»²½Ñо¿¡£Æä´Î £¬Ö§³Öϸ°ûµÄ SARS-CoV-2 ѬȾ¿ÉÄÜ»á¼Ì·¢ÐÔËðº¦Ðá¾õ¸ÐÊÜÉñ¾­Ôª (OSN) £¬´Ó¶øË𺦻¯Ñ§ÆøÏ¢ÐÅÏ¢ÏòÐáÇò (OB) µÄ´«µ¼¡£ÔÚСÊóºÍÈËÀàÖÐ £¬ÔÚOBµÄÖ§³Öϸ°û£¨SCs£©¡¢Ðá¾õ¸Éϸ°ûºÍѪ¹ÜÖÜΧϸ°û£¨ÖÜϸ°û£©Öмì²âµ½ace2±í´ï £¬µ«ÔÚOSNÖÐδ¼ì²âµ½¡£±ðµÄ £¬ÔÚÈËÌå»î¼ìÖÐ £¬ÔÚÐá¾õÆ÷¹Ù (OO) µÄ¹ÌÓвãºÍ SCs Öмì²âµ½²¡¶¾ RNA £¬Åú×¢ OSNs ²»¾­³£±»Ñ¬È¾¡£±ðµÄ £¬Óà SARS-CoV-2 ѬȾ½ð»ÆµØÊó»áµ¼ÖÂ´ó²¿·Ö SC ѬȾ £¬µ«²»»áѬȾ OSN £¬È»¶øOSNÊÜË𠣬ÏËëµÄ´ó×Úȱʧ֤ʵÎúÕâÒ»µã¡£×ÛÉÏËùÊö £¬SARS-CoV-2ѬȾSCs¿ÉÄÜ»á¸Ä±äÕû¸öOOµÄ¾Ö²¿´úлºÍÑ×֢״̬ £¬´Ó¶øµ¼ÖÂOSNÊÜËðºÍËæºóµÄÐá¾õȱʧ¡£SARS-CoV-2 Spike (S) ÂÑ°×ÊÇͬԴÈý¾ÛÌå £¬Ã¿¸öµ¥ÌåÓÉÒ»¸ö S1 ÑÇ»ùºÍÒ»¸ö S2 ÑÇ»ù×é³É¡£S1 ÑÇ»ù°üÀ¨Ò»¸ö N ¶Ë½á¹¹ÓòºÍÊÜÌåÍŽá½á¹¹Óò (RBD)¡£ SARS-CoV-2 S RBD ÓëËÞÖ÷ϸ°ûÉϵÄѪ¹ÜÖ÷ÒªËØת»»Ã¸ 2 (ACE2) ÍŽá £¬È»ºóË¿°±ËáÂÑ°×ø£¨Èç TMPRSS2£©Çиî´ÌÍ»ÂÑ°× S1/S2 λµã £¬ÒÔÔö½ø²¡¶¾Á£×ÓÓëËÞÖ÷ϸ°ûĤµÄÈںϡ£Ò»µ© RBD Óë ACE2 ÍŽá £¬¾Í»á±¬·¢¸´ºÏÎïµÄÄÚÍÌ×÷Óᣠһµ©½øÈëϸ°ûÄÚ £¬S ÂѰ׿ÉÄܻᱻ½µ½â £¬²¢ÇÒ¿ÉÄÜ»á´ÓÊÜѬȾµÄϸ°ûÖÐÊͷųöÓÎÀëµÄ S ÂÑ°×Ƭ¶Ï¡£ÊÂʵÉÏ £¬¾ÝÍƲâ £¬ÊÜѬȾµÄϸ°ûºÍ²¡¶¾Á£×Ó»áÍÑÂäÓÎÀëµÄ¿ÉÈÜÐÔ S1 ÑÇ»ù £¬ÕâЩÑÇ»ù¿ÉÒÔÍŽá ACE2 ²¢µ¼ÖÂÏÂÓÎÓк¦×÷ÓúÍÑ×Ö¢¡£ËäÈ»ÕâÒ»¼ÙÉèÐèÒª½øÒ»²½µÄʵÑéÖ§³Ö £¬µ«²¡¶¾ÑÜÉúµÄÂÑ°×ÖÊ £¬ÈçÀ´×Ô¹Ú×´²¡¶¾ºÍ HIV µÄÌÇÂÑ°× £¬Òѱ»Ö¤Êµ¿ÉÔÚÍâÖÜѪϸ°ûÖÐÓÕµ¼ IFN ·´Ó¦¡£±ðµÄ £¬ÒѾ­¼Í¼Á˶Բ¡¶¾ÂÑ°×µÄÉñ¾­Ñ×Ö¢·´Ó¦ £¬×ÝÈ»ÔÚûÓÐ×Ô¶¯Ñ¬È¾µÄÇéÐÎÏ¡£ÀýÈç £¬ÎÒÃÇÒѾ­Ö¤ÊµÑ¬È¾ÐÔÔìѪ»µËÀ²¡¶¾µÄÌÇÂÑ°×£¨GÂÑ°×£©×ãÒÔ´¥·¢Ó²¹ÇÓãµÄ±ÇÉñ¾­ÃâÒß·´Ó¦¡£»ùÓÚÕâÏîÑо¿ £¬ÎÒÃǼÙÉèSARS-CoV-2 S RBDÂÑ°××ãÒÔÒýÆðÐá¾õ²¡ÀíѧºÍ¹¦Ð§ÕÏ°­¡£°ßÂíÓãµÄÐá¾õϵͳÔÚ·Ö×ÓÏ¢ÕùÆÊѧÉÏÓëÈËÀàÓкܺéÁ÷ƽµÄÏàËÆÐÔ°ßÂíÓãOOÓÉ̻¶ÔÚÍⲿÇéÐÎÖеÄÁ½¸ö×ÔÁ¦±Ç¿××é³É £¬OSNÖ±½Ó¼ì²âÇéÐÎË®ÖеĻ¯Ñ§´Ì¼¤¡£±Ç¿×ÓÉÐí¶àÐá¾õ°å¡¢Ö¸×´½á¹¹×é³É £¬Ã¿Ò»¸ö¶¼ÁýÕÖ×ŷǸÐÊܺ͸ÐÊÜÉñ¾­ÉÏƤ¡£¸ÐÊÜÇøÓÉ»ùÄÚÇé°û¡¢ÖÐÐÄÉñ¾­ÔªÇ°Ìå¡¢³ÉÊìµÄOSNºÍÖ§³Öϸ°û×é³É £¬ÀàËÆÓÚ²¸È鶯ÎïµÄOE¡£OSNÖáÍ»³ÉÊø´©¹ý»ùµ×²ã £¬ÔÚ¹ÌÓвãÐγÉÐáË¿¡£ÔÚ¹ÌÓвãÖÐ £¬³ýÁËOSNÖáÍ»ÊøÍâ £¬»¹·¢Ã÷³ÉÏËάϸ°û¡¢½ºÖÊϸ°ûºÍѪ¹Ü¡£°ßÂíÓã OO ÒÑÔÚ²î±ðµÄ¶¾ÎïºÍËðÉËÄ£×ÓÖоÙÐÐÁËÆÕ±éÑо¿¡£°ßÂíÓã OO ºÍ OB µÄÔÙÉúÄÜÁ¦Åú×¢Ðá¾õ»Ö¸´µÄ¶¯Á¦Ñ§Ô¼ÄªÐèÒª 2 ÖÜ£» ÓëÔÚ»¼ÓÐÐá¾õÕÏ°­µÄ COVID-19 »¼ÕßÖÐÊӲ쵽µÄÏàËƵĻָ´Ê±¼ä±í¡£ÓëÆäËû¶¯ÎïÄ£×ÓÏà±È £¬°ßÂíÓã¾ßÓÐ×ÌÉúÄÜÁ¦Ç¿¡¢·¢ÓýѸËÙ¡¢Î¬»¤±¾Ç®µÍ¡¢ÉíÌåС¶ø͸Ã÷µÈÓŵã¡£ÔÚÒÅ´«Ñ§ÉÏ £¬Áè¼Ý80%µÄ¼²²¡Ïà¹Ø»ùÒò¾ßÓаßÂíÓãֱϵͬԴ»ùÒò £¬²¢ÇÒÔÚ°ßÂíÓã»ùÒò×éÖÐÒÑÅжϳöËùÓÐÖ÷Òª²¸È鶯Îïϸ°ûÒò×Ó×é³ÉÔ±¡£

һЩÑо¿ÒѾ­Ìá³ö°ßÂíÓã×÷ΪSARS-CoV-2µÄÄ£×Ó¡£ÊµÑéͨ¹ý½þÅÝѬȾҰÉúÐÍ°ßÂíÓã×ÐÓãÅú×¢ SARS-CoV-2 ȱ·¦Ñ¬È¾»ò¸´ÖÆ¡£½«SARS-CoV-2²¡¶¾Î¢Á¿×¢Éäµ½Ò°ÉúÐÍ°ßÂíÓãÓ×ÌåÖÐ £¬·¢Ã÷ÔÚ°òë×ÖÐÓÐÊʶȸ´ÖÆ £¬Í¨¹ýÆäËû;¾¶Î¢Á¿×¢ÉäʱûÓи´ÖÆ¡£Ê¹ÓÃÒ°ÉúÐÍ°ßÂíÓ㣨×ÐÓã»ò³ÉÓ㣩À´ÏàʶSARS-CoV-2ѬȾÊÇÓÐÏ޵ġ£³ÉÄêÓ²¹ÇÓãOO´ËÇ°Òѱ»Ö¤Êµ¶ÔÀ´×Ô²¡Ô­ÌåµÄÂÑ°×ÖÊÓз´Ó¦¡£ÔÚ±¾Ñо¿ÖÐ £¬ÎÒÃÇÑо¿ÁËSARS-CoV-2 S RBD ÂÑ°×ÔÚ BSL-1 ÇéÐÎÖж԰ßÂíÓãÐá¾õϵͳµÄÓ°Ïì¡£±¾Ñо¿Ê״α¨¸æ±ÇÄÚ (I.N.) ×¢Èë SARS-CoV-2 S RBD ×ãÒÔÒýÆð³ÉÄê°ßÂíÓãµÄÐá¾õ²¡±ä¡£ËðÉËÊǶÌÔÝµÄ £¬ÓÉÓÚ×éÖ¯ÔÚ 2 ÖÜÄÚ»ñµÃÐÞ¸´¡£ µçÐÄÀíѧ½øÒ»²½Åú×¢³ÉÄê°ßÂíÓãÔÚ I.N. ºó¶ÔÆøÏ¢µÄ¹¦Ð§·´Ó¦ÊÜË𠣬ֻ¹ÜËüÃÇûÓÐʧȥ¶ÔʳÎïÆøÏ¢µÄÐÐΪƫºÃ¡£

¼¹×µ¶¯ÎïACE2·Ö×ӵĽÏÁ¿ÆÊÎö£ºACE2 ÂÑ°×ÊÇÈËÀàϸ°ûÉÏ SARS-CoV-2 S RBD µÄÊÜÌå £¬²¢ÔÚ²¸È鶯Îï OE µÄÖ§³Öϸ°ûÖбí´ï¡£¼¹×µ¶¯ÎïѪ¹ÜÖ÷ÒªËØת»»Ã¸2£¨ACE2£©·Ö×ӵĽÏÁ¿ÆÊÎöÅú×¢ £¬°ßÂíÓãACE2ºÍÈËÀàACE2Ö®¼äµÄÏàËÆÐÔ»®·ÖΪ72%-73%ºÍ57.5%-58%¡£¶ÔSARS-CoV-2 SÂÑ°×ÍŽáÇøÓòµÄACE2°±»ùËá¾ÙÐмì²â·¢Ã÷°ßÂíÓãACE2ÔÚÍŽá½çÃæ´¦µÄ°±»ùËá¾ßÓÐÊʶȵÄÊؾÉÐÔ¡£×ÛºÏÆðÀ´ £¬ÕâЩÊý¾ÝÓë֮ǰµÄ±¨µÀÒ»Ö £¬Åú×¢Ó²¹ÇÓã ACE2 ÂѰײ»Ì«¿ÉÄÜÓë SARS-CoV-2 S ÍŽá¡£

SARS-CoV-2 S RBD µÄ±ÇÄÚ×¢Èëµ¼Ö³ÉÄê°ßÂíÓãµÄÐá¾õËðÉË£ºÐá¾õËðʧÊÇÈËÀàѬȾ SARS-CoV-2 µÄ×îÔçÌåÏÖÖ®Ò»¡£ÎÒÃÇ֮ǰÒѾ­Ö¤Êµ £¬IHNVÌÇÂÑ°××ãÒÔÓÕµ¼Ó²¹ÇÓãµÄ¿ìËÙ±ÇÃâÒß·´Ó¦ºÍÉñ¾­Ôª¼¤»î¡£Òò´Ë £¬ÎÒÃǼÙÉèÖØ×éSARS-CoV-2 S RBDÂѰ׿ÉÄÜ×ãÒÔËðÉË°ßÂíÓãµÄOO¡£ÎªÁËÑéÖ¤ÕâÒ»¼ÙÉè £¬ÎÒÃǽ«ÖØ×éSARS-CoV-2 S RDB×¢Èë³ÉÄêAB°ßÂíÓãµÄ±ÇÇ» £¬²¢ÔÚ3Сʱ£¨h£©¡¢1Ì죨d£©¡¢3Ì죨d£©¡¢5Ì죨d£©ºÍ2ÖÜ£¨w£©ºó²ÉÑùOO¡£ÒõÐÔ±ÈÕÕ°üÀ¨½ö½ÓÊܸ³ÐμÁ (PBS) ×¢Èë±ÇÇ»µÄ¶¯ÎïÒÔ¼°½ÓÊÜÏàͬ¼ÁÁ¿ r-CK12a µÄÓã¡£ ÎÒÃÇ»¹°üÀ¨Ò»¸ö Poly(I:C) ×¢Èë×é×÷Ϊ dsRNA ÓÕµ¼µÄ¿¹²¡¶¾×÷ÓõÄÌØÊâ±ÈÕÕ¡£ÔÚ¼ì²éµÄËùÓÐÔçÆÚʱ¼äµã £¬SARS-CoV-2 S RBD ×ãÒÔ¶Ô°ßÂíÓã OO Ôì³ÉÑÏÖØË𺦡£ÔÚ×¢Èëºó3Сʱ £¬ÔçÆÚ×éÖ¯ËðÉ˵ÄÌØÕ÷¾ÍÊǹÌÓв㷺ÆðË®Ö׺ÍÄÚƤÑ×Ö¢¡£×¢Èëºó1ÌìÊӲ쵽Ðá°å¼â¶ËºÍµ×²¿·ºÆð³öѪ¡£ÔÚ 3 h ʱÔÚÉÏƤÖÐÊӲ쵽ˮÖ× £¬ÒÔ×éÖ¯ÖеĿÕǻΪÌØÕ÷ £¬µ«µ½ 1 d¡¢3 d ºÍ 5 d ʱ £¬ÔÚÕû¸ö¹ÌÓв㷢Ã÷Ë®Öס£±ðµÄ £¬Í¨¹ýÕÉÁ¿¾àÖзì 50 ¦Ìm ´¦¹ÌÓвãµÄ¿í¶ÈÀ´Á¿»¯Ë®Ö× £¬²¢·¢Ã÷ÔÚ I.N×¢Èë SARS-CoV-2 S RBDºó 3 СʱºÍ 3 Ìì¹ÌÓвãÏÔÖøÀ©ÕÅ¡£×¢Èëºó1Ìì¡¢3ÌìºÍ5Ìì £¬ÊӲ쵽Ӳ¹ÇÓãÐá¾õÉÏƤµÄÉÏƤÏâǶ½á¹¹È±Ê§¡£×¢Èëºó5ÌìÔÚSARS-CoV-2 S RBD×¢ÈëµÄ¶¯ÎïÖÐÊӲ쵽ÓÉÓÚÑÏÖØ»µËÀµ¼ÖµÄÕû¸öÐá°å²ãɥʧ £¬¶ø±ÈÕÕ¶¯ÎïûÓÐÐá°å²ãɥʧ¡£ÔÚËùÓÐÔçÆÚʱ¼äµã £¬ËùÓнÓÊÜSARS-CoV-2 S RBD×¢ÈëµÄ¶¯ÎﶼÊӲ쵽Ðá°åÏËëÏÔÖøȱʧ¡£½ÓÊÜ r-CK12a »ò Poly(I:C) µÄ°ßÂíÓãûÓÐÊӲ쵽Ðá¾õËðÉË¡£ÆÀ¹À I.N. ºó OO µÄ»Ö¸´ÇéÐΡ£ ÎÒÃÇÔÚ×¢Èëºó2Öܼì²éÁË×éÖ¯ÇÐƬ¡£¶Ô°ßÂíÓãÐá¾õϵͳ¿ÉËÜÐÔµÄÑо¿Åú×¢ £¬ÔÚ OO »¯Ñ§ÏûÈÚ 2 Öܺó £¬½á¹¹ºÍ¹¦Ð§µÃÒÔ»Ö¸´¡£ÔÚI.N.SARS-CoV-2 S RBDºó2ÖܵÄOOÓë¾­¸³ÐμÁ×¢ÈëµÄOOÏàËÆ¡£Éñ¾­ÉÏƤÏâǶÐÞ¸´£»Ã»ÓÐË®Ö× £¬ÏËë¿´ÆðÀ´ºÜ¿µ½¡¡£ÕâЩЧ¹ûÅú×¢ £¬SARS-CoV-2 S RBD×ãÒÔÔÚ°ßÂíÓãOOÖÐÔì³ÉÑÏÖص«¶ÌÔݵÄ×éÖ¯ËðÉË £¬ÔÚȱ·¦»îÔ¾µÄSARS-CoV-2¸´ÖƵÄÇéÐÎÏ £¬¿ÉÄܱ¬·¢Ðá¾õËðÉË¡£

image.png

ͼ1¡¢±ÇÄÚ×¢ÈëSARS-CoV-2 S RDBÂÑ°×»á¶Ô³ÉÄê°ßÂíÓãÔì³ÉÑÏÖصÄ×é֯ѧËðÉË £¬²¢ÔÚ2Öܺó»Ö¸´¡£

ΪÁ˶¨Î»ÖØ×éSARS-CoV-2 S RBDÂÑ°×ÓëOOÖ®¼äµÄÏ໥×÷Óà £¬ÔÚSARS-CoV-2 S RBDÖØ×éÂÑ°××¢Èë15·ÖÖÓºó £¬ÎÒÃǶÔÔÚ³ÉÊìÏËëOSNÖÐÄÚÔ´ÐÔ±í´ïºìÉ«Ó«¹âÂÑ°×£¨RFP£©µÄOMP:lynRFP¶¯Îï¾ÙÐÐÁË¿¹His¿¹ÌåÃâÒßÓ«¹âȾɫ¡£SARS-CoV-2 S RBDÂÑ°×ÆÕ±éÂþÑÜÓڷǸÐÊÜÉÏƤ £¬¿¹-HisÑôÐÔÇøÓòȱ·¦RFPÐźžÍ֤ʵÎúÕâÒ»µã¡£±ðµÄ £¬Ò°ÉúÐÍ°ßÂíÓãÔÚ½ÓÊÜSARS-CoV-2 S RBD×¢Èë15·ÖÖÓºóµÄ·Ç¸ÐÊÜÇøÓò·Å´óͼÏÔʾ £¬ÑØ×Å°å²ãµÄ·Ç¸ÐÊÜÉÏƤÇøÓò±£´æÓÐÏ޵ĵã×´¿¹HisȾɫ¡£SARS-CoV-2 S RBD×¢Èë15·ÖÖӵĶ¯ÎïµÄͬÐͱÈÕÕȾɫºÍ¸³ÐμÁ×¢È붯ÎïÉϵĿ¹-HisȾɫÔÚÕâЩÇøÓò¾ùδÏÔʾÐźÅ¡£ÎªÁËÆÀ¹À°ßÂíÓãͬϵÎïace2ÊÇ·ñÔÚ°ßÂíÓãµÄÐá¾õϵͳÖбí´ï £¬Í¨¹ýqPCRÕÉÁ¿±ÈÕÕ³ÉÄê°ßÂíÓãµÄOOºÍOBÉϵÄת¼ˮƽ¡£ÎÒÃÇ֤ʵÁË°ßÂíÓãOOÖÐace2µÄÖжȱí´ïˮƽ £¬¶øOBÖÐace2µÄ±í´ïˮƽºÜÊǵÍ¡£Òò´Ë £¬SARS-CoV-2 S RBD¿ÉÄÜÓë°ßÂíÓãOOÖеÄAce2Ï໥×÷Óà £¬Ö»¹Ü²»¿Éɨ³ýÅäÌå-ÊÜÌåÏ໥×÷ÓõÄÆäËû»úÖÆ¡£

±ÇÄÚ×¢ÈëSARS-CoV-2 S RBD¸ÄÄð³ÉÄê°ßÂíÓãµÄ¹ÌÓв㣺ƾ֤H&EÆÊÎö £¬×¢ÈëSARS-CoV-2 S RBDºó°ßÂíÓãOO 3D¹ÌÓвãÖÐÏÔ×ű£´æ´óµÄÏËά°ß¿é¡£·Î×éÖ¯ÏËά»¯ÊÇ SARS-CoV-2 ºÍ SARS-CoV »¼Õߵıê¼Ç £¬ÆäÌØÕ÷ÊdzÉÏËάϸ°ûÒ»Á¬±£´æÒÔ¼°½ºÔ­ÂѰ׺ÍÆäËûϸ°ûÍâ»ùÖÊÒòËصÄÌ«¹ý³Á»ý¡£ÎªÁËÈ·¶¨ÔÚ°ßÂíÓã¹ÌÓвãÖÐÊӲ쵽µÄת±äÊÇ·ñÓë·ÎÏËά»¯Öз¢Ã÷µÄת±äÏàËÆ £¬ÎÒÃǾÙÐÐÁËMassonÈýɫȾɫ £¬½«½ºÔ­À¶È¾¡£Óë±ÈÕÕ×éÏà±È £¬SARS-CoV-2 S RBD¶¯ÎïÔÚ3Сʱ»ò3ÌìÄÚÀ¶É«È¾É«µÄ½ºÔ­ÂѰ׳Á»ýûÓÐÔöÌí¡£È»¶ø £¬ÔÚ 3 d ʱÊӲ쵽´ó×ÚÏʺìÉ«µÄ³Á»ýÎï £¬Åú×¢±£´æÓÚ×¢È붯Îï¹ÌÓвãÖеÄÏËάÖÊÁÏÓɽÇÂÑ°××é³É £¬¿ÉÄÜÓÐÖúÓÚ×éÖ¯ÓúºÏ¡£Ï¸°û½ÇÂÑ°× 8 (CTK8) ÊÇ°ßÂíÓãÔÙÉúÀú³ÌÖеıíƤ±ê¼ÇÎï¡£±ÈÕÕ³ÉÄê°ßÂíÓã OO ÖÐµÄ CTK8 ȾɫÏÔʾ·Ç¸ÐÊÜÉÏƤÒÔ¼° SCs ºÍ»ùÄÚÇé°ûÖеÄÑôÐÔȾɫģʽ¡£I.N. Poly(I:C)×¢ÈëûÓиıä OO ÖÐµÄ CTK8 Ⱦɫģʽ¡£ÔÚI.N.SARS-CoV-2 S RBDºó3Сʱ £¬·Ç¸ÐÊÜÉÏƤÏâǶ½á¹¹±»ÆÆËð£»×æϸ°ûˮƽ»ùÄÚÇé°ûͨ³£ÓɱâƽÐÎ̬±äÔ² £¬Öù×´SCs²»Ì«ÏÔ×Å¡£SARS-CoV-2 S RBDºó3Ìì £¬·Ç¸ÐÊÜÉÏƤ¸ß¶ÈÔÓÂÒ £¬¹ÌÓвãµÄһЩϸ°ûÖзºÆðCTK8Ⱦɫ £¬Óë±ÈÕÕ×é»ò¹ÌÓвãCTK8ÒõÐÔµÄ3СʱOOÑù±¾ÐγÉÏÊÃ÷±ÈÕÕ¡£

ͼ 2. SARS-CoV-2 S RDB ÂѰ׵ıÇÄÚ×¢Èëµ¼Ö³ÉÄê°ßÂíÓã OO ±¬·¢ÑÏÖصÄϸ°ûת±ä¡£

ÎÒÃǺܺÃÆæCTK8ÃâÒß·´Ó¦Ä£Ê½µÄÕâÖÖת±äÊÇ·ñÊÇÓÉÓÚ¹ÌÓвãºÍOEÊÜËðºóOOµÄϸ°û¶¯Á¦Ñ§¸Ä±äËùÖ¡£Òò´Ë £¬ÎÒÃÇʹÓÿ¹PCNA¿¹ÌåÀ´ÆÀ¹À´¦ÓÚϸ°ûÆÆËéºÏ³É½×¶ÎµÄϸ°û¡£ÓÃͬÐͱÈÕÕ¶ø·Ç¿¹PCNA¿¹ÌåȾɫµÄOO±ù¶³ÇÐƬÏÔʾûÓп¹Ìå·´Ó¦¡£Ó븳ÐμÁ×¢ÈëµÄOOÏà±È £¬ÔÚI.N.SARS-CoV-2 S RBDºó3СʱºÍ3Ìì £¬PCNA·´Ó¦ÑôÐÔµÄϸ°ûÊýÄ¿ÏÔÖøÔöÌí¡£ÓëÒÔÍù¶Ô°ßÂíÓãOOµÄÑо¿ÀàËÆ £¬´ó´ó¶¼PCNAÑôÐÔϸ°ûλÓڷǸÐÊÜÉÏƤÖÐ £¬Ö»¹ÜÓÐЩϸ°ûλÓÚ°å²ãµÄ¸ÐÊÜÇø¡£×¢ÉäSARS-CoV-2 S RBDºó3ÌìµÄPCNAÑôÐÔϸ°ûÊýÄ¿Óë×¢É䲡¶¾Ä£ÄâÎïpoly£¨I:C£©ºó3ÌìµÄPCNAÑôÐÔϸ°ûÊýÄ¿²î±ð £¬ÕâÓëÁ½¸ö×¢Èë×éÖ®¼äÊӲ쵽µÄ×é֯ѧ²î±ðÏàºôÓ¦¡£±ðµÄ £¬ÓÉÓÚ OSN ÏËëµÄɥʧ £¬ÎÒÃǺܺÃÆæÉñ¾­ÉÏƤÄÚµÄϸ°ûÊÇ·ñµòÍö¡£ÓÃͬÖÖÐͱÈÕÕ¶ø²»ÊÇ¿¹¼¤»îµÄ caspase-3 ¿¹ÌåȾɫµÄ OO À䶳ÇÐƬÏÔʾûÓп¹Ìå·´Ó¦ÐÔ¡£ÎÒÃÇ·¢Ã÷ I.N ºó3 СʱºÍ 3 ÌìµòÍöϸ°ûÏÔÖøÔöÌí¡£ SARS-CoV-2 S RBD ÔÚ 3 h ºÍ 3 d ʱÖ÷ҪλÓڷǸÐÊÜÉÏƤϸ°ûÖÐ £¬ÔÚ 3 d ʱһЩϸ°û´Ø·ºÆðÔÚ¸ÐÊÜÉÏƤϸ°ûÖС£ÔÚ±¾Ñо¿ÖÐ £¬Óë֮ǰÔÚ÷®ÓãÖеķ¢Ã÷Ïà±È £¬µ¥´Î×¢È벡¶¾Ä£ÄâÎïpoly£¨I:C£©²»»áµ¼ÖÂÏÔÖøµÄϸ°ûµòÍö £¬µ«Èý´Î×¢Èëpoly£¨I:C£©È·Êµ»áµ¼ÖÂϸ°ûµòÍö¡£

±ÇÄÚ×¢ÈëSARS-CoV-2 S RBD»áµ¼ÖÂÐá¾õȱʧµ«²»»á¸ÄÄð³ÉÄê°ßÂíÓãµÄʳÎïÆ«ºÃ£ºÓëԤעÈë¶ÔʳÎïÆøÏ¢µÄ·´Ó¦Ïà±È £¬³ÉÄê°ßÂíÓãI.N.¸øÓè SARS-CoV-2 S RBD¶ÔʳÎïÌáÈ¡ÎïµÄÐá¾õ·´Ó¦Ë²¼äÏÔ׎µµÍ £¬Ðá¾õµçͼ¼Í¼ (EOG) µÄÕñ·ù½µµÍÁË 50%¡£Ì»Â¶ÓÚSARS-CoV-2 S RBDºó1·ÖÖÓÄÚ £¬Ðá¾õ·´Ó¦½µµÍ £¬Åú×¢Ðá¾õ¹¦Ð§±¬·¢ÁË˲¼äת±ä¡£Ã¿5·ÖÖӼͼһ´Î¶ÔʳÎïÆøÏ¢µÄÐá¾õ·´Ó¦4Ãë £¬Ò»Á¬1Сʱ¡£ÔÚ 5 ·ÖÖӵľàÀëÆÚ £¬ÓÃË®³åÏ´ OO ÒÔɨ³ý¶àÓàµÄÆøÏ¢²¢×èֹ̫¹ý̻¶µ¼Ö OSN ÍÑÃô¡£¾­ SARS-CoV-2 S RBD ×¢ÈëµÄÓã¶ÔʳÎïÌáÈ¡ÎïµÄÐá¾õ·´Ó¦½µµÍÒ»Á¬ 1 Сʱ¡£±ÈÕÕ×鶯Îï¶ÔʳÎïÆøÏ¢µÄ·´Ó¦ÔÚÈκÎʱ¼äµã¶¼Ã»ÓÐïÔÌ­¡£Õâ֤ʵÁËSARS-CoV-2 S RBD×¢Èë¸öÌå¶ÔʳÎïÌáÈ¡ÎïµÄÐá¾õ·´Ó¦½µµÍ²¢·ÇÓÉÓÚÌ«¹ý̻¶ÓÚʳÎïÆøÏ¢µ¼ÖÂOSNÍÑÃô £¬¶øÊÇÓëOOÊÜËðÓйØ¡£ÎªÁ˽øÒ»²½Á¿»¯ I.N. SARS-CoV-2 S RBDÒýÆðµÄÐá¾õ½µµÍˮƽ £¬ÎÒÃÇʹÓÃÁË°ßÂíÓãÖб£´æµÄÁ½¸ö×ÔÁ¦µÄÐá¾õÊÒ £¬½«Í³Ò»¶¯ÎïµÄÒ»¸ö±Ç¿×̻¶ÓÚ SARS-CoV-2 S RBD ÂÑ°× £¬½«Í³Ò»¶¯ÎïµÄÁíÒ»¸ö±Ç¿×̻¶ÓÚ¸³ÐμÁ (PBS) ²¢ÆÚ´ý 3 Сʱ¡¢1 Ìì¡¢3 Ìì»ò 2 ÖÜ £¬È»ºóͨ¹ý EOG ÕÉÁ¿Ðá¾õ¡£ÎÒÃÇÊӲ쵽3СʱSARS-CoV-2 S RBD±Ç¿×¶ÔʳÎïºÍµ¨Ö­µÄÐá¾õ·´Ó¦»®·Ö±È¸³ÐμÁ×¢ÈëµÄ±Ç¿×ïÔÌ­49%ºÍ44% £¬ÔÚ×¢Èëºó1Ìì £¬Ê³ÎïºÍµ¨Ö­Ðá¾õ·´Ó¦µÄÐá¾õ¹¦Ð§»®·ÖïÔÌ­60%ºÍ89%¡£½ÓÊÜSARS-CoV-2 S RBD×¢ÈëµÄ±Ç¿×ÖÐ £¬Ò»Ð©¸öÌåÔÚ1Ììºó¶Ôµ¨Ö­Ã»ÓÐEOG·´Ó¦¡£¶ÔʳÎïÌáÈ¡ÎïµÄÐá¾õÃô¸ÐÐÔ½µµÍСÓÚµ¨Ö­ £¬Õâ¿ÉÄÜÊÇÓÉÓÚÓëʳÎïÖз¢Ã÷µÄ°±»ùËáÏà±È £¬¼ÓÈ뵨֭Ëá¼ì²âµÄ OSN ÊýÄ¿½ÏÉÙ¡£SARS-CoV-2 S RBD×¢Èë2Öܺó £¬±Ç¿×Ö®¼äµÄEOG·´Ó¦Ã»Óвî±ð¡£Ó븳ÐμÁ×¢ÈëµÄ±Ç¿×Ïà±È £¬×¢Èë±ÈÕÕÖØ×éÂÑ°×£¨r-CK12a£©ºó3h¡¢1d¡¢3dºÍ2w¶ÔʳÎïºÍµ¨Ö­µÄEOG·´Ó¦Ã»ÓÐÏÔÖø²î±ð¡£ÌÚ²©»á¹ÙÍøЧ¹ûÅú×¢ £¬EOG ÊӲ쵽µÄ SARS-CoV-2 S RBD ÓÕµ¼µÄÐá¾õËðʧ²¢·ÇÌض¨ÓÚ OSN µÄÒ»¸ö×Ó¼¯ £¬ÓÉÓÚSARS-CoV-2 S RBD ×¢ÈëµÄ°ßÂíÓãÖÐʳÎïÌáÈ¡ÎïºÍµ¨Ö­Ðá¾õÐźžùÊܵ½ÒÖÖÆ¡£

1-s20-S0889159122000745-gr3.jpg

ͼ 3. SARS-CoV-2 S RDB ÂѰ׵ıÇÄÚ×¢Èëµ¼Ö³ÉÄê°ßÂíÓãÐá¾õËðʧ¡£

°ßÂíÓãÐá¾õÆ÷¹ÙµÄµ¥Ï¸°ûÆÊÎö£ºÎªÁ˸üºÃµØÏàʶSARS-CoV-2 S RBDÓÕµ¼³ÉÄê°ßÂíÓãÐá¾õ¹¦Ð§ÕÏ°­µÄ»úÖÆ £¬ÎÒÃǾÙÐÐÁ˵¥Ï¸°ûRNA-Seq£¨scRNA-Seq£©Ñо¿¡£¼øÓÚÌÚ²©»á¹ÙÍø×é֯ѧ·¢Ã÷ºÍ SARS-CoV-2 S RBD Óë·Ç¸ÐÊÜÉÏƤÇøÓòµÄÍŽá £¬ÎÒÃǼÙÉèת¼ÈŶ¯ÓÉÓÚ¼ä½Ó»úÖƶø±¬·¢ÔÚÖ§³Öϸ°ûºÍ OSN ÖС£ÔÚ×¢ÈëSARS-CoV-2 S RBD 3Сʱ»ò3Ììºó¾ÙÐÐscRNA-Seq¡£ÎÒÃǹ²Åжϳö8¸öÉñ¾­Ï¸°û´Ø£¨NC£©¡¢5¸öSC´Ø¡¢3¸öÄÚƤϸ°û´Ø£¨EC£©ºÍ7¸ö°×ϸ°û´Ø£¨ÁܰͺÍËèϸ°û£©¡£

±ÇÄÚ×¢ÈëSARS-CoV-2 S RBD¿ÉÓÕµ¼³ÉÄê°ßÂíÓãÐá¾õÆ÷¹ÙµÄÑ×Ö¢·´Ó¦ºÍÆÕ±éµÄÐá¾õÊÜÌå±í´ïËðʧ£º¼øÓÚ´Ó×é֯ѧºÍϸ°û¶¯Á¦Ñ§ÊӲ쵽µÄÐÎ̬ת±äÒÔ¼° EOG ¶ÔÆøÏ¢µÄ·´Ó¦¸Ä±ä £¬ÎÒÃǼÙÉè SARS-CoV-2 S RBD ÖÎÁƵ¼Ö OSN µÄת¼×éת±ä¡£°ßÂíÓã OO µÄϸ°û¾°¹ÛÊܵ½ SARS-CoV-2 S RBD ×¢ÈëºÍʱ¼äµÄÓ°Ïì¡£Óë±ÈÕÕ×éºÍ3СʱÖÎÁÆ×éÏà±È £¬ÔÚÖÎÁƺó3Ìì £¬±í´ïompµÄ³ÉÊìÏËëOSNµÄ±ÈÀýÏÔÖø½µµÍ £¬ÕâÔÚÉñ¾­ÔªÏ¸°ûÀàÐ͵ıÈÀýÖÐÓÈΪÏÔ×Å¡£Ïà±È֮Ϡ£¬±í´ïϸ°ûÖÜÆÚ±ê¼ÇÎaubk¡¢ecrg4ºÍmki67£©ºÍÉñ¾­Ôª·Ö½âºÍ¿ÉËÜÐÔ±ê¼ÇÎneurod1¡¢neurod4¡¢gap43¡¢sox11ºÍsox4£©µÄÉñ¾­Ôª×æϸ°ûÔÚÖÎÁƺó3ÌìÀ©Ôö¡£ÓÐȤµÄÊÇ £¬Óë±ÈÕÕ×éÏà±È £¬ÔÚ´Ó COVID-19 ºÍ¼×ÐÍÁ÷¸Ð»¼ÕßËÀºóÈËÌåʵÖÊÍøÂçµÄ¸ü¶àµ¥ºËת¼×éÖз¢Ã÷ÁËÐí¶àÕâЩ¿ÉËÜÐÔÏà¹ØµÄ»ùÒò¡£±ðµÄ £¬¼ì²âµ½ÊôÓÚÁÜ°Íϸ°û2´ØµÄϸ°û±ÈÀýÏÔÖøϽµ £¬¸Ã´ØÔÚ×¢ÈëÖØ×éSARS-CoV-2 S RBDºó3Сʱ±í´ïTregϸ°û±ê¼ÇÎfoxp3b£©¡£ÔÚµÚ 3 Ìì £¬ÎÒÃÇÊӲ쵽µÚÈý¸öÁÜ°Íϸ°û´Ø £¬µ«ÔÚ 3 Сʱδ¼ì²âµ½¸Ãϸ°û´Ø¡£¸Ã·Ö×ÓÔÚ²¸È鶯ÎïµÄTh1ÐÍÃâÒß·´Ó¦ÖоßÓÐÃâÒßµ÷Àí×÷Óá£ÕâЩЧ¹ûÅú×¢ £¬°ßÂíÓãOOµÄÉñ¾­ÔªºÍÃâÒßϸ°ûÑÇȺ¶ÔSARS-CoV-2 S RBDÓÐÖ÷ÒªµÄϸ°û·´Ó¦¡£

×ÜÖ® £¬ÌÚ²©»á¹ÙÍøÑо¿Åú×¢ £¬SARS-CoV-2 S1ÂÑ°×µÄÒ»¸öƬ¶ÏRBD¿Éµ¼Ö³ÉÄê°ßÂíÓãµÄÐá¾õ²¡ÀíѧºÍÐá¾õËðʧ¡£ÌÚ²©»á¹ÙÍøÑо¿Ð§¹ûÖ§³Ö²¡¶¾ÑÜÉúÂÑ°×ÈçSARS-CoV-2 S RBD¿ÉÄܾßÓÐÉñ¾­¶¾ÐÔ×÷ÓõĿ´·¨¡£±¾Ñо¿Ìá³öÁËÓëËÞÖ÷ѬȾ SARS-CoV-2 ºó S1 ºÍ S1 ÑÜÉúÂÑ°×Ƭ¶ÏµÄÉú»¯Ï໥×÷ÓÃÓйصÄÖ÷ÒªÎÊÌâ¡£ÈôÊÇRBD»òÆäËûS1Ƭ¶ÏÔÚÌåÄÚÊÍ·Å £¬ÓÎÀ벡¶¾ÂѰ׵ı£´æ¿ÉÄܻᵼÖ»ò¼Ó¾ç²¡¶¾²¡ÀíÐÄÀíËðÉË¡£½øÒ»²½µÄÑо¿¿ÉÒÔΪÕâÒ»¼Ù˵ÌṩʵÑéÖ§³Ö¡£

Ô­Îijö×Ô£ºIntranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish - ScienceDirect

ÉÏһƪ£º2014Äê¶È¹ú¼ÒʵÑ鶯ÎïÖÖ×ÓÖÐÐÄÉú³¤×êÑлáÔÚ¹þ¶û±õÕÙ¿ª ÏÂһƪ£ºÑо¿°ßÂíÓãÕ¹ÏÖÆ÷¹ÙÔÙÉúÖ®ÃÕ

Ïà¹ØÔĶÁ ¸ü¶à>>

²ÂÄúϲ»¶¸ü¶à>>

¶¯ÎïÊÔÑé

ÁÙ´²Åàѵ

Ä¥Á·¼°²¡Àí

ÁÙ´²ÊÔÑé

²úÆ·×¢²á

 

ÌìÏÂÃâ·Ñ×Éѯ:

ÓªÒµ×Éѯ£º17312606166£¨É¡Ë¾Àí£©

½Ú¼ÙÖµ°à£º17312606166£¨Î¢Ðźţ©

ÁªÏµµØµã£º
ËÕÖÝ£ºËÕÖÝÊÐËÕÖݹ¤ÒµÔ°ÇøʤÆÖ½ÖµÀÐËÆÖ·200ºÅ
Ì©ÖÝ£º½­ËÕÊ¡Ì©ÖÝÊÐÒ½Ò©¸ßÐÂÇøÐãˮ·20ºÅ19´±
¹ãÖÝ£º¹ãÖÝÊÐÀóÍåÇø»¨µØ´óµÀÖÐ228ºÅ

Copyright © 2018-2024 ÌÚ²©»á¹ÙÍø      ICP±¸°¸£ºËÕICP±¸17068211ºÅ Ö§³Öµ¥Î»£ºÌÚ²©»á¹ÙÍø

ÔÚÏß
¿Í·þ

ÊÖÒÕÔÚÏßЧÀÍʱ¼ä£º9:00-20:00

ÔÚÌÚ²©»á¹ÙÍø £¬Äú¶Ô½ÓµÄÊÇÊÖÒÕÖ°Ô± £¬¶ø·Ç¿Í·þ´«»°£¡

  • ´ó¶¯ÎïÊÔÑé
  • ÁÙ´²Åàѵ
  • ×éÖ¯²¡Àí
  • ÁÙ´²ÊÔÑé
  • ²úÆ·×¢²á
  • ¿ÆÑпÎÌâ

µç»°
×Éѯ


7*24Сʱ¿Í·þÈÈÏß

17312606166
ÏîĿ˾ÀíÊÖ»ú

΢ÐÅ
×Éѯ

¼Ó΢ÐÅ»ñÈ¡¶Ô½Ó
¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿